- Home
- LENZ vs PUBM Comparison
LENZ vs PUBM Comparison
Compare LENZ & PUBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- PUBM
- Stock Information
- Founded
- LENZ 2019
- PUBM 2006
- Country
- LENZ United States
- PUBM United States
- Employees
- LENZ N/A
- PUBM N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- PUBM Computer Software: Prepackaged Software
- Sector
- LENZ Health Care
- PUBM Technology
- Exchange
- LENZ Nasdaq
- PUBM Nasdaq
- Market Cap
- LENZ 886.2M
- PUBM 778.6M
- IPO Year
- LENZ 2021
- PUBM 2020
- Fundamental
- Price
- LENZ $32.63
- PUBM $15.44
- Analyst Decision
- LENZ Strong Buy
- PUBM Buy
- Analyst Count
- LENZ 6
- PUBM 8
- Target Price
- LENZ $35.40
- PUBM $20.57
- AVG Volume (30 Days)
- LENZ 154.8K
- PUBM 319.8K
- Earning Date
- LENZ 11-06-2024
- PUBM 11-12-2024
- Dividend Yield
- LENZ N/A
- PUBM N/A
- EPS Growth
- LENZ N/A
- PUBM 553.89
- EPS
- LENZ N/A
- PUBM 0.32
- Revenue
- LENZ N/A
- PUBM $290,354,000.00
- Revenue This Year
- LENZ N/A
- PUBM $12.37
- Revenue Next Year
- LENZ N/A
- PUBM $7.80
- P/E Ratio
- LENZ N/A
- PUBM $48.10
- Revenue Growth
- LENZ N/A
- PUBM 13.11
- 52 Week Low
- LENZ $2.33
- PUBM $13.18
- 52 Week High
- LENZ $38.93
- PUBM $25.36
- Technical
- Relative Strength Index (RSI)
- LENZ 50.06
- PUBM 43.11
- Support Level
- LENZ $28.90
- PUBM $16.10
- Resistance Level
- LENZ $33.30
- PUBM $17.10
- Average True Range (ATR)
- LENZ 2.54
- PUBM 0.64
- MACD
- LENZ -0.62
- PUBM -0.17
- Stochastic Oscillator
- LENZ 42.03
- PUBM 15.20
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About PUBM PubMatic Inc.
PubMatic is one of the leading supply-side platform providers in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, better manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). PubMatic generates revenue mainly via taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Given the growth in overall digital advertising, more publishers and advertisers are adopting programmatic (or automated) buying and selling, driving the firm's success in attracting more inventory.